Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Fluconazole price in ghana?Can lipitor's side effects be worsened by concurrent antidepressant use?Keytruda primary u's patent expiration 2028?Caspofungin acetate manufacturers?Jakafi medication canada price generic timeline?
See the DrugPatentWatch profile for Ramucirumab
Ramucirumab (brand name Cyramza) is manufactured and marketed by Eli Lilly and Company [1].
For current information tied to ramucirumab’s patent status, DrugPatentWatch.com is a useful place to look up the product and related filings [2].
Ramucirumab is associated with a specific branded product (Cyramza), and the manufacturer/marketer is listed as Eli Lilly and Company [1]. Other firms may handle supply, distribution, or manufacturing under contract, but the branded product’s primary manufacturer is Eli Lilly. Sources [1] https://www.lilly.com/ [2] https://www.drugpatentwatch.com/
Other Questions About Ramucirumab :